MedTrace Logo

German SLD-Registry (Deutsches SLD-Register)

NCT04721665 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-03-06

No results posted yet for this study

Summary

Characterization of patients with steatotic liver disease (SLD)

The German SLD-Registry (Deutsches SLD-Register) a project of the German Liver Foundation (Deutsche Leberstiftung), managed by Leberstiftungs-GmbH Deutschland.

The German NAFLD-Registry is financially supported by: Advanz Pharma Specialty Medicine Deutschland GmbH und Gilead Sciences GmbH (Grant to German Livber Foundation) sowie Novo Nordisk Pharma GmbH (directly via Leberstiftungs-GmbH).

Conditions

  • Steatotic Liver Disease

Sponsors & Collaborators

  • Leberstiftungs-GmbH Deutschland

    lead INDUSTRY

Principal Investigators

  • Stefan Zeuzem, Prof. Dr. · Johann Wolfgang Goethe University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2036-11-30
Completion
2036-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04721665 on ClinicalTrials.gov